Search - tctmd.com

Displaying 1 - 20 of 67

Sort: Relevancy | Date

News Conference News AHA 2025

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Michael O'Riordan

November 11, 2025

News Daily News

BMJ Investigation Revives Questions About PLATO, Ticagrelor

Todd Neale

December 20, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

Experts Warn of Looming Private Equity Interest in Cardiology Care

Michael O'Riordan

January 15, 2024

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Conference News ESC 2023

ESC/EACTS Task Force Recommends Downgrading PCI in Left Main CAD

Michael O'Riordan

September 05, 2023

News Daily News

CABG and PCI Comparable in ACS Patients With Left Main CAD

Michael O'Riordan

June 06, 2023

News Daily News

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

Michael O'Riordan

April 27, 2022

News Conference News AHA 2021

No Mortality Difference Between PCI and CABG for Left Main CAD: Meta-analysis

Michael O'Riordan

November 15, 2021

News Conference News ACC 2021

Even With Stent Cards, Patients Often Hazy on PCI Details Years Later

Michael O'Riordan

May 11, 2021

News Conference News SCAI 2021

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

Michael O'Riordan

May 06, 2021

News Daily News

Tocilizumab Improves Myocardial Salvage After STEMI: ASSAIL-MI

Michael O'Riordan

April 12, 2021

News Daily News

Stable CAD With High-Risk Anatomy Warrants PCI or CABG, APPROACH Suggests

Michael O'Riordan

January 05, 2021

News Conference News AHA 2020

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

Shelley Wood

November 15, 2020

News Conference News AHA 2020

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

Michael O'Riordan

November 14, 2020

News Conference News TCT 2020

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

Todd Neale

October 21, 2020

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

News Daily News

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Michael O'Riordan

June 01, 2020

News Daily News

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Michael O'Riordan

May 15, 2020

News

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Michael O'Riordan

April 17, 2020

Advertisement

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

BMJ Investigation Revives Questions About PLATO, Ticagrelor

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Experts Warn of Looming Private Equity Interest in Cardiology Care

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

ESC/EACTS Task Force Recommends Downgrading PCI in Left Main CAD

CABG and PCI Comparable in ACS Patients With Left Main CAD

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

No Mortality Difference Between PCI and CABG for Left Main CAD: Meta-analysis

Even With Stent Cards, Patients Often Hazy on PCI Details Years Later

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

Tocilizumab Improves Myocardial Salvage After STEMI: ASSAIL-MI

Stable CAD With High-Risk Anatomy Warrants PCI or CABG, APPROACH Suggests

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content